Pay in 4 interest-free payments of $6.76 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
Risks include inaccurate dosing, contamination, and poor storage
For most employer plans, the right approach is clinical criteria that allow prescriber discretion based on individual patient factors, with prior authorization ensuring appropriate utilization regardless of which product is selected
People with a personal or family history of Medullary Thyroid Carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) should not use either medication
doi: 10.1056/NEJMoa2404881Retrieved from Novo Nordisk
US$ 21.25
US$ 28.67
US$ 22.88
US$ 29.97
